{"id":"NCT00667355","sponsor":"Abbott","briefTitle":"A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis","officialTitle":"A Multi-Center, Open-Label Efficacy, Safety, and Pharmacokinetic Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2009-05","completion":"2011-01","firstPosted":"2008-04-28","resultsPosted":"2010-08-11","lastUpdate":"2012-01-26"},"enrollment":41,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondylitis"],"interventions":[{"type":"BIOLOGICAL","name":"adalimumab","otherNames":["ABT-D2E7","Humira"]}],"arms":[{"label":"Adalimumab","type":"EXPERIMENTAL"}],"summary":"To evaluate efficacy, safety and pharmacokinetics of adalimumab in Japanese subjects with active ankylosing spondylitis","primaryOutcome":{"measure":"Number of Subjects Achieving Assessment in Ankylosing Spondylitis 20 (ASAS 20) at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Adalimumab","deltaMin":30,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":19,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":41},"commonTop":["Nasopharyngitis","Hepatic function abnormal","Diarrhoea","Upper respiratory tract infection","Upper respiratory tract inflammation"]}}